These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 31111916)
21. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects. Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814 [TBL] [Abstract][Full Text] [Related]
22. High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma. Zhou L; van Bree N; Boutin L; Ryu J; Moussaud S; Liu M; Otrocka M; Olsson M; Falk A; Wilhelm M Neuro Oncol; 2024 Sep; 26(9):1685-1699. PubMed ID: 38860311 [TBL] [Abstract][Full Text] [Related]
23. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. Robinson GW; Orr BA; Wu G; Gururangan S; Lin T; Qaddoumi I; Packer RJ; Goldman S; Prados MD; Desjardins A; Chintagumpala M; Takebe N; Kaste SC; Rusch M; Allen SJ; Onar-Thomas A; Stewart CF; Fouladi M; Boyett JM; Gilbertson RJ; Curran T; Ellison DW; Gajjar A J Clin Oncol; 2015 Aug; 33(24):2646-54. PubMed ID: 26169613 [TBL] [Abstract][Full Text] [Related]
24. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma. Rodriguez-Blanco J; Li B; Long J; Shen C; Yang F; Orton D; Collins S; Kasahara N; Ayad NG; McCrea HJ; Roussel MF; Weiss WA; Capobianco AJ; Robbins DJ Clin Cancer Res; 2019 Feb; 25(4):1379-1388. PubMed ID: 30487124 [TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224 [TBL] [Abstract][Full Text] [Related]
26. Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation. Hellwig M; Merk DJ; Lutz B; Schüller U Cancer Gene Ther; 2020 May; 27(5):294-300. PubMed ID: 31068675 [TBL] [Abstract][Full Text] [Related]
27. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma. Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257 [TBL] [Abstract][Full Text] [Related]
28. A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog-Dependent Tumor Growth. Yang F; Rodriguez-Blanco J; Long J; Swiderska-Syn M; Wynn DT; Li B; Shen C; Nayak A; Ban Y; Sun X; Suter RK; McCrea HJ; Capobianco AJ; Ayad NG; Robbins DJ Mol Cancer Res; 2022 Nov; 20(11):1598-1610. PubMed ID: 35925047 [TBL] [Abstract][Full Text] [Related]
29. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation. Tan IL; Wojcinski A; Rallapalli H; Lao Z; Sanghrajka RM; Stephen D; Volkova E; Korshunov A; Remke M; Taylor MD; Turnbull DH; Joyner AL Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3392-3397. PubMed ID: 29531057 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E1 Inhibits Wu F; Zhang C; Zhao C; Wu H; Teng Z; Jiang T; Wang Y Cancer Res; 2020 Jul; 80(13):2818-2832. PubMed ID: 32371475 [TBL] [Abstract][Full Text] [Related]
31. scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy. Ocasio JK; Babcock B; Malawsky D; Weir SJ; Loo L; Simon JM; Zylka MJ; Hwang D; Dismuke T; Sokolsky M; Rosen EP; Vibhakar R; Zhang J; Saulnier O; Vladoiu M; El-Hamamy I; Stein LD; Taylor MD; Smith KS; Northcott PA; Colaneri A; Wilhelmsen K; Gershon TR Nat Commun; 2019 Dec; 10(1):5829. PubMed ID: 31863004 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide. Ghorbanlou M; Moradi F; Shabani R; Mehdizadeh M J Chemother; 2024 Oct; 36(6):506-519. PubMed ID: 38130211 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists. Mo J; Liu F; Sun X; Huang H; Tan K; Zhao X; Li R; Jiang W; Sui Y; Chen X; Shen K; Zhang L; Ma J; Zhao K; Tang Y Cancer Res; 2021 Jun; 81(11):3105-3120. PubMed ID: 33853831 [TBL] [Abstract][Full Text] [Related]
34. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma. Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282 [TBL] [Abstract][Full Text] [Related]
35. Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth. Di Magno L; Manzi D; D'Amico D; Coni S; Macone A; Infante P; Di Marcotullio L; De Smaele E; Ferretti E; Screpanti I; Agostinelli E; Gulino A; Canettieri G Cell Cycle; 2014; 13(21):3404-13. PubMed ID: 25485584 [TBL] [Abstract][Full Text] [Related]
36. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740 [TBL] [Abstract][Full Text] [Related]
37. Hedgehog pathway permissive conditions allow generation of immortal cell lines from granule cells derived from cancerous and non-cancerous cerebellum. Heil C Open Biol; 2019 Jan; 9(1):180145. PubMed ID: 30958113 [TBL] [Abstract][Full Text] [Related]
38. Disruption of the ciliary GTPase Arl13b suppresses Sonic hedgehog overactivation and inhibits medulloblastoma formation. Bay SN; Long AB; Caspary T Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1570-1575. PubMed ID: 29378965 [TBL] [Abstract][Full Text] [Related]
39. Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells. Scheidt T; Alka O; Gonczarowska-Jorge H; Gruber W; Rathje F; Dell'Aica M; Rurik M; Kohlbacher O; Zahedi RP; Aberger F; Huber CG Cell Commun Signal; 2020 Jun; 18(1):99. PubMed ID: 32576205 [TBL] [Abstract][Full Text] [Related]
40. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]